- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Defining Value in Cancer Care
The shift to focus on value in healthcare has changed the definition of what it means to be a physician in the United States, and professional societies, such as the American Society of Clinical Oncology (ASCO) are thinking about this issue heavily in order to provide guidance to their members, said Pete P. Yu, MD, FACP, FASCO, president of ASCO.
%jwplayer%
The shift to focus on value in healthcare has changed the definition of what it means to be a physician in the United States, and professional societies, such as the American Society of Clinical Oncology (ASCO) are thinking about this issue heavily in order to provide guidance to their members, said Pete P. Yu, MD, FACP, FASCO, president of ASCO.
During his keynote speech, Dr Yu discussed the problem of measurement—namely, that healthcare does not have strong outcomes measures. Without those, it is difficult to determine what value truly is.
“Having more robust outcomes measures is key to improve the value of what we as physicians do,” he explained.
He also highlighted the results of an annual ASCO survey of oncology practices that revealed a 25% reduction in private practices from 2012 to 2013, with mostly smaller practices joining larger ones or being bought by hospitals. This shift represents a barrier to access to care since small and medium practices see a third of new cancer patients.
During his keynote, Dr Yu also promoted ASCO’s Quality Oncology Practic Initiative, which certifies practices based on their performance in areas of patient care and safety; offered principles for a value-based payment reform initiative; and discussed ASCO’s CancerLinQ data platform.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
